TERT and cancer: One extensively analyzed TF binding mutation in human cancers is located in the TERT promoter region, which creates a new canonical binding motif TTCCGG for oncogenic E26 transformation-specific (ETS) factors; this gained motif allows ETS proteins to bind to the mutated promoter to trigger TERT expression, resulting in uncontrolled cell proliferation and eventual tumorigenesis (7).